Skip to main content

Table 3 Weighted multivariate logistic regression analyses of associations of periodontitis stage with circadian syndrome

From: Association of periodontitis, tooth loss, and self-rated oral health with circadian syndrome in US adults: a cross-sectional population study

Periodontitis stage

Model 1

Model 2

Model 3

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

Circadian syndrome

     

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.38 (1.10, 1.73)

0.006

1.30 (1.03, 1.64)

0.030

1.35 (1.03, 1.76)

0.032

 Stage III (n = 2944)

1.42 (1.12, 1.80)

0.005

1.19 (0.92, 1.55)

0.200

1.30 (0.97, 1.73)

0.069

 Stage IV (n = 1190)

1.71 (1.27, 2.31)

 < 0.001

1.14 (0.84, 1.54)

0.400

1.17 (0.82, 1.65)

0.300

Obesity

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.23 (0.98, 1.54)

0.070

1.21 (0.95, 1.53)

0.110

1.21 (0.94, 1.57)

0.120

 Stage III (n = 2944)

1.24 (1.00, 1.55)

0.054

1.16 (0.93, 1.46)

0.200

1.20 (0.94, 1.54)

0.130

 Stage IV (n = 1190)

1.22 (0.93, 1.60)

0.140

0.96 (0.73, 1.26)

0.800

0.97 (0.72, 1.32)

0.800

Elevated FPG

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.06 (0.83, 1.34)

0.600

1.03 (0.80, 1.33)

0.800

1.04 (0.79, 1.37)

0.800

 Stage III (n = 2944)

1.34 (1.04, 1.74)

0.027

1.24 (0.93, 1.65)

0.120

1.29 (0.94, 1.75)

0.100

 Stage IV (n = 1190)

1.46 (1.15, 1.86)

0.003

1.20 (0.92, 1.58)

0.200

1.22 (0.90, 1.65)

0.200

Hypertension

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.36 (1.05, 1.76)

0.023

1.32 (1.00, 1.74)

0.050

1.35 (0.99, 1.84)

0.054

 Stage III (n = 2944)

1.42 (1.11, 1.82)

0.007

1.30 (0.98, 1.73)

0.065

1.39 (1.01, 1.92)

0.044

 Stage IV (n = 1190)

1.76 (1.31, 2.36)

 < 0.001

1.44 (1.01, 2.05)

0.044

1.49 (1.01, 2.20)

0.047

Low HDL

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.28 (1.06, 1.55)

0.013

1.24 (1.01, 1.52)

0.041

1.27 (1.02, 1.59)

0.036

 Stage III (n = 2944)

1.32 (1.08, 1.61)

0.009

1.18 (0.94, 1.47)

0.140

1.25 (0.98, 1.60)

0.068

 Stage IV (n = 1190)

1.53 (1.15, 2.05)

0.005

1.16 (0.86, 1.57)

0.300

1.19 (0.86, 1.66)

0.300

Elevated TG

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.28 (1.08, 1.52)

0.006

1.25 (1.05, 1.48)

0.017

1.28 (1.05, 1.56)

0.022

 Stage III (n = 2944)

1.30 (1.03, 1.64)

0.027

1.17 (0.91, 1.50)

0.200

1.24 (0.93, 1.64)

0.120

 Stage IV (n = 1190)

1.57 (1.22, 2.01)

 < 0.001

1.24 (0.95, 1.61)

0.110

1.27 (0.94, 1.70)

0.100

Short sleep

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.08 (0.78, 1.51)

0.600

0.96 (0.68, 1.34)

0.800

0.97 (0.67, 1.38)

0.800

 Stage III (n = 2944)

1.42 (1.03, 1.96)

0.032

1.05 (0.75, 1.47)

0.700

1.08 (0.76, 1.54)

0.600

 Stage IV (n = 1190)

1.70 (1.19, 2.45)

0.005

0.96 (0.65, 1.42)

0.800

0.96 (0.64, 1.44)

0.800

Depression

 Stage I (n = 806)

1.00

 

1.00

 

1.00

 

 Stage II (n = 4224)

1.15 (0.93, 1.42)

0.200

0.95 (0.75, 1.21)

0.700

1.00 (0.75, 1.32)

 > 0.900

 Stage III (n = 2944)

1.25 (0.97, 1.62)

0.086

0.80 (0.59, 1.07)

0.120

0.87 (0.62, 1.23)

0.400

 Stage IV (n = 1190)

1.75 (1.23, 2.49)

0.003

0.76 (0.51, 1.13)

0.200

0.75 (0.47, 1.17)

0.200

  1. In the weighted multivariable logistic regression models, the reference group was participants with stage I periodontitis. The outcome variables were circadian syndrome and the seven components of circadian syndrome. Model 1: adjusting periodontitis stage, age, sex and race. Model 2: adjusting periodontitis stage, age, sex, race, educational levels, family income, marital status, smoking status, drinking status, physical activity, and dietary quality. Model 3: adjusting periodontitis stage, age, sex, race, educational levels, family income, marital status, smoking status, drinking status, physical activity, dietary quality, working condition, working hours and taking medicines status. Data are shown as OR and 95% CI. Significant values are shown in bold
  2. Abbreviations: CI Confidence interval, OR Odds ratio, FPG Fasting Plasma Glucose, HDL High-density lipoprotein cholesterol, TG triglycerides